环孢素A通过诱导铁死亡增强胰腺癌细胞的放疗敏感性OA
Cyclosporine A enhances the radiosensitivity of pancreatic cancer cells by inducing ferroptosis
目的 探讨环孢素A(CsA)联合放射治疗对胰腺癌细胞增敏作用及其机制.方法 通过网络药理学分析筛选CsA、铁死亡与胰腺癌放疗增敏的共同作用靶点,进行富集分析和分子对接预测.在体外实验中,采用人胰腺癌细胞系BxPC-3和MIA PaCa-2进行研究.细胞分为5组:对照组、CsA组、照射组、CsA+照射组、CsA+照射+铁死亡抑制剂(Fer-1)组.使用细胞计数试剂盒-8(CCK-8)法检测CsA对胰腺癌细胞活性的影响,筛选适宜浓度用于后续实验;通过台盼蓝染色实验和集落形成实验评估细胞存活率及增殖情况;采用流式细胞术检测细胞凋亡;BODIPY 581/591 C11探针检测细胞内脂质过氧化水平;实时荧光定量PCR(RT-qPCR)和Western印迹检测长链脂酰辅酶A合成酶4(ACSL4)、溶质载体家族7成员11(SLC7A11)和谷胱甘肽过氧化物酶4(GPX4)的mRNA和蛋白表达.结果网络药理学分析预测结果显示,CsA可能通过关键靶点SLC7A11调控铁死亡通路.体外实验结果显示,与对照组比较,CsA处理后,胰腺癌细胞的活力显著降低,且呈浓度依赖性.CsA与放射治疗联合使用时,表现出协同增效作用.与单独照射组比较,CsA联合照射显著抑制细胞活性、降低细胞存活率、减少集落形成,并促进细胞凋亡.这些效果可以通过Fer-1部分逆转.在机制方面,CsA联合照射显著诱导了脂质过氧化,且相较于单独照射组,SLC7A11和GPX4的mRNA和蛋白表达显著下调,而ACSL4的mRNA和蛋白表达则显著上调.Fer-1能够特异性地逆转这些调控效应.结论 CsA通过调控SLC7A11/GPX4/ACSL4信号轴诱导铁死亡,增强胰腺癌细胞的放疗敏感性.
Objective To investigate the sensitizing effect of cyclosporine A(CsA)in combination with radiation therapy on pancreatic cancer cells(BxPC-3 and MIA PaCa-2)and explore the underlying mechanisms.Methods Network pharmacology was used to identify the common targets between CsA,ferroptosis,and radiosensitization for pancreatic cancer,followed by enrichment analysis and molecular docking predictions.In vitro experiments were performed using BxPC-3 and MIA PaCa-2 pancreatic cancer cell lines.Cells were divided into five groups:control,CsA alone,irradiation alone,CsA plus irradiation,and CsA plus irradiation plus Ferrostatin-1(Fer-1).The CCK-8 assay was used to assess the effect of CsA on cell viability and determine the optimal concentration for subsequent experiments.Cell survival and proliferative capacity were evaluated via trypan blue staining and clonogenic assays.Apoptosis was measured by flow cytometry,and lipid peroxidation levels were determined using the BODIPY 581/591 C11 probe.Real-time quantitative PCR(RT-qPCR)and Western blotting were used to analyze the expressions of ACSL4,SLC7A11,and GPX4 at both the mRNA and protein levels.Results Network pharmacology analysis suggested that CsA might regulate the ferroptosis pathway through the key target SLC7A11.In vitro experiments showed that CsA significantly reduced pancreatic cancer cell viability in a concentration-dependent manner compared to the control group,with a synergistic effect when combined with irradiation.Compared with the irradiation-alone group,the combination of CsA and irradiation significantly reduced cell viability,inhibited cell proliferation,decreased colony formation,and promoted apoptosis.These effects were partially reversed by the ferroptosis inhibitor Fer-1.Mechanistically,the combination of CsA with irradiation significantly induced lipid peroxidation,downregulated the expressions of SLC7A11 and GPX4,and upregulated the expression of ACSL4,all of which were reversed by Fer-1.Conclusion CsA enhances the radiosensitivity of pancreatic cancer cells by modulating the SLC7A11/GPX4/ACSL4 signaling axis to induce ferroptosis.This study provides evidence for clinical applications of CsA as a ferroptosis-inducing radiosensitizer in pancreatic cancer.
赵纪伟;申星;余祖胤;孙刚;彭疏篁;刘涵菲;王婧;纪奥强;陈怡;张瀚文;吴俊嶺;王淑芳
解放军总医院第一医学中心,北京 100853||军事科学院军事医学研究院,北京 100850军事科学院军事医学研究院,北京 100850军事科学院军事医学研究院,北京 100850解放军总医院第一医学中心,北京 100853解放军总医院第一医学中心,北京 100853解放军总医院第一医学中心,北京 100853解放军总医院第一医学中心,北京 100853军事科学院军事医学研究院,北京 100850解放军总医院第一医学中心,北京 100853解放军总医院第一医学中心,北京 100853解放军总医院第一医学中心,北京 100853解放军总医院第一医学中心,北京 100853
医药卫生
环孢素A胰腺癌放射敏感性铁死亡放射治疗网络药理学
cyclosporine Apancreatic cancerradiosensitivityferroptosisradiation therapynetwork pharmacology
《军事医学》 2026 (7)
489-497,9
军队高层次科技创新人才工程学科拔尖人才培育项目(GCCRC-2024-002)
评论